Cidara Therapeutics (20D0.F) Q2 2025 Earnings

8MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-18.18
-12.61
-7.04
-1.48

Details

Expected EPS
-3.15629473641
Actual EPS
-1.4786781999999998
Surprise EPS
1.68
Surprise Percent
+53.15%

Description

Cidara Therapeutics (20D0.F) has reported earnings of -1.4786781999999998 per share for Q2 2025.

0 Comments

Share your thoughts